
The $65,000 Cancer Cure: Inside the Indian Lab That Is Taking on a Half‑Million‑Dollar Industry — and Winning
On a Tuesday morning in March, a child in Vellore who had exhausted every option became the first patient in India to receive a CAR‑T therapy designed in a Delhi laboratory. The treatment took less than an hour. The child went home. The cost of the infusion — the cells, the engineering, the quality control, the cold‑chain logistics — was roughly one‑eighth of what the same therapy would have cost at a major American cancer center.








